Table 2 Baseline laboratory data.
From: Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT
Critically ill ALF patients (N = 7) | Critically ill ACLF patients (N = 7) | |
|---|---|---|
Hemoglobin (g/dL) | 9.1 ± 1.4 | 9.0 ± 2.2 |
White blood cells (× 103/µL) | 12.6 ± 8.2 | 23.5 ± 11.0 |
Platelets (× 103/µL) | 55.4 ± 33.1 | 100.4 ± 55.3 |
BUN (mg/dL) | 30.6 ± 24.8 | 27.9 ± 11.8 |
Cr (mg/L) | 1.5 ± 1.2 | 1.8 ± 1.0 |
Sodium (mmol/L) | 135 ± 6 | 136 ± 5 |
Potassium (mmol/L) | 3.7 ± 0.5 | 4.2 ± 0.8 |
Bicarbonate (mmol/L) | 22.3 ± 2.9 | 21.7 ± 5.2 |
Calcium (mg/dL) | 8.8 ± 0.9 | 8.3 ± 1.6 |
Magnesium (mg/dL) | 0.9 ± 0.1 | 0.9 ± 0.1 |
Phosphate (mg/dL) | 2.3 ± 0.9 | 4.1 ± 2.5 |
Total bilirubin (mg/dL) | 19.5 ± 8.9 | 11.1 ± 5.1 |
Direct bilirubin (mg/dL) | 11.3 (9.8,14.5) | 6.2 (3.6, 11.2) |
AST (U/L) | 128 (50,355) | 165 (58,614) |
ALT (U/L) | 120 (23,352) | 112 (21,224) |
ALP (U/L) | 130 (78,170) | 165 (99,183) |
Albumin (g/L) | 3.2 ± 0.7 | 3.3 ± 0.5 |
PT (s) | 21.2 ± 8.8 | 27.4 ± 15.2 |
INR | 1.9 (1.4, 2.6) | 1.8 (1.6, 3.9) |
aPTT (s) | 36.3 (27.7, 52.0) | 51.5 (34.5, 84.5) |
pH | 7.42 ± 0.06 | 7.39 ± 0.08 |
Lactate (mmol/L) | 3.26 ± 2.83 | 5.47 ± 2.00 |
Ionized calcium (mmol/L) | 1.18 ± 0.10 | 1.08 ± 0.22 |
Ionized magnesium (mmol/L) | 0.59 ± 0.11 | 0.51 ± 0.07 |
